Artificial Pancreas Device System (APDS) Market
- 2026 年市場規模
- USD 487.60 Mn
- 2033 年預估規模
- USD 1,634.2 Mn
- 年複合成長率 CAGR
- 18.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Artificial Pancreas Device System (APDS) Market, By Technology (Threshold Suspended Device Systems, Treat to Range/Control to Range (TTR/CTR), and Treat to Target/ Control to Target (TTR/CTT)), By Distribution Channel (Hospitals & Clinics, Online Channels, and Retail Channels), By Geography(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Type 1 diabetes patients require multiple doses of insulin in a day. Advancements in research and technology has led to commercialization of easy-to-use insulin delivery systems such as insulin pens, pumps, inhaled insulin, and injectors. Use of syringes to deliver insulin has become obsolete with the introduction of advanced and easy-to-use insulin delivery systems.
Moreover, these systems offer self-administration of insulin. Artificial pancreas system automatically detects glucose level in patient’s blood or plasma, and accordingly administers necessary dosage of insulin. For instance, Medtronic's MiniMed 670G is one such wearable artificial pancreas that automatically monitors glucose levels, and delivers insulin through an insulin pump attached to the device. The artificial pancreas technology includes a transmitter, sensor, and insulin pump. This helps in continuous monitoring of insulin levels in body and manages diabetes at ease.
Market Dynamics
Continuous research and development of novel artificial pancreas device systems is expected to support the artificial pancreas device system (APDS) market growth over the forecast period.
For instance, in May 2019, Beta Bionics, Inc. and Zealand Pharma started an in-home trial of iLet Bionic Pancreas system, a dual-hormone pump system designed to automatically deliver insulin and dasiglucagon – an experimental form of glucagon designed by Zealand Pharma to be stable in liquid form- based on blood sugar readings from a continuous glucose monitor (CGM).
High prevalence of diabetes type 1 is expected to rise demand for its novel monitoring systems and drive the artificial pancreas device system (APDS) market growth over the forecast period.
For instance, according to the World Health Organization (WHO), number of diabetes patients worldwide increased from 108 million in 1980 to 422 million in 2014. Furthermore, according to the Center for Disease Control and Prevention (CDC), type 1 diabetes accounts for around 5% of the total diagnosed diabetes cases in adults in the U.S.
Key features of the study
• This report provides in-depth analysis of global artificial pancreas device system (APDS) market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026 – 2033), considering 2025, as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global artificial pancreas device system (APDS) market based on following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Medtronic Plc., Medtrum Technologies Inc., Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Inc., Bigfoot Biomedical, Insulet Corporation, Pancreum, Inc., TypeZero Technologies, Inc., DreaMed Diabetes Ltd, and Inreda Diabetic BV
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global artificial pancreas device system (APDS) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global artificial pancreas device system (APDS) market
Market Segmentation
• By Technology
o Threshold Suspended Device Systems
o Treat to Range/Control to Range (TTR/CTR)
o Treat to Target/ Control to Target (TTR/CTT)
• By Distribution Channel
o Hospitals & Clinics
o Retail Channel
o Online Channel
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Artificial Pancreas Device System Market Companies
o Medtronic Plc.
o Medtrum Technologies Inc.
o Tandem Diabetes Care, Inc.
o Johnson & Johnson
o Beta Bionics, Inc.
o Bigfoot Biomedical
o Insulet Corporation
o Pancreum, Inc.
o TypeZero Technologies, Inc.
o DreaMed Diabetes Ltd
o Inreda Diabetic BV
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Technology
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Restraints
o Market Opportunities
o Impact Analysis
o Technology Assessment
o Reimbursement
o Regulatory Scenario
o Product Launch/Approval
o Merger and Acquisitions/Collaborations
o Product Pipeline Analysis
o Pricing Analysis
o PEST Analysis
4. Global Artificial Pancreas Device System (APDS) Market, By Technology, 2026 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026–2033
Segment Trends
o Threshold Suspended Device Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Treat to Range/Control to Range (TTR/CTR)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Treat to Target/ Control to Target (TTR/CTT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
5. Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel, 2026 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026–2033
Segment Trends
o Hospitals & Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Retail Channel
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Online Channel
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Artificial Pancreas Device System (APDS) Market, By Region, 2026 – 2033 (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
o North America
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033 (USD Mn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033 (USD Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033 (USD Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033 (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Country/Region, 2026 – 2033 (USD Mn)
o Central Africa
o South Africa
o North Africa
o Middle East
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033 (USD Mn)
o GCC
o Israel
o Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Medtronic Plc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Medtrum Technologies Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Tandem Diabetes Care, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Johnson & Johnson
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Beta Bionics, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Bigfoot Biomedical
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Insulet Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Pancreum, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
TypeZero Technologies, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
DreaMed Diabetes Ltd
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Inreda Diabetic BV
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
8. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們